ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years
Ji Li
Matched on ORCID iD 0000-0002-9842-4885; OpenAlex author ID A5075194049. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 38
2022: 2 papers · 2023: none · 2024: none · 2025: 1 paper
Papers 3
- Periarterial divestment for borderline and locally advanced pancreatic cancer: An analysis of 125 cases in a single center. Co-author DOI 10.1016/j.surg.2025.109412↗
- Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of pancreatic cancer. Co-author DOI 10.1016/j.jncc.2022.08.006↗
- CDCA8/SNAI2 Complex Activates CD44 to Promote Proliferation and Invasion of Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/cancers14215434↗
Closest collaborators
The 25 strongest of 38 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Feng Yang · 1 shared paper, 2025 · strength 0.30
- Chen Jin · 1 shared paper, 2025 · strength 0.30
- Hang He · 1 shared paper, 2025 · strength 0.30
- Deliang Fu · 1 shared paper, 2025 · strength 0.30
- Deliang Fu · 2 shared papers, 2022 · strength 0.24
- Paper CDCA8/SNAI2 Complex Activates CD44 to Promote Proliferation and Invasion of Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers14215434↗
- Paper Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of pancreatic cancer. DOI 10.1016/j.jncc.2022.08.006↗
- Jichun Gu · 1 shared paper, 2022 · strength 0.15
- Baian Tao · 1 shared paper, 2022 · strength 0.15
- Junyuan Deng · 1 shared paper, 2022 · strength 0.15
- Lei Kong · 1 shared paper, 2022 · strength 0.15
- Jiali Du · 1 shared paper, 2022 · strength 0.15
- Hengchao Li · 1 shared paper, 2022 · strength 0.15
- Feng Jiao · 1 shared paper, 2022 · strength 0.09
- Zheng Wang · 1 shared paper, 2022 · strength 0.09
- Zhiwei Li · 1 shared paper, 2022 · strength 0.09
- Tao Zhang · 1 shared paper, 2022 · strength 0.09
- Qingyong Ma · 1 shared paper, 2022 · strength 0.09
- Liwei Wang · 1 shared paper, 2022 · strength 0.09
- Chunyi Hao · 1 shared paper, 2022 · strength 0.09
- Gang Ren · 1 shared paper, 2022 · strength 0.09
- Jie Chen · 1 shared paper, 2022 · strength 0.09
- Dan Cao · 1 shared paper, 2022 · strength 0.09
- Jian Wang · 1 shared paper, 2022 · strength 0.09
- Yongrui Bai · 1 shared paper, 2022 · strength 0.09
- Zhihong Zhang · 1 shared paper, 2022 · strength 0.09
- Yongwei Sun · 1 shared paper, 2022 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.